This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Ge Healthcare UK Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Michael Edward Cooper: Innovator in Fluorescence Labelling Reagents
Introduction
Michael Edward Cooper is a notable inventor based in Cardiff, GB. He has made significant contributions to the field of fluorescence labelling reagents, particularly through his innovative work on cyanine dyes. His research has implications for various biological applications, enhancing the detection and analysis of biological materials.
Latest Patents
Cooper holds a patent for "Water-soluble fluoro-substituted cyanine dyes as reactive fluorescence labelling reagents." This patent discloses cyanine dyes that are particularly useful for labelling and detecting biological and other materials. The dyes are characterized by a specific formula where at least one of the groups includes fluorine. The invention aims to reduce dye-dye aggregation and improve photostability, making these dyes especially valuable in assays requiring fluorescence detection.
Career Highlights
Michael Edward Cooper is associated with GE Healthcare UK Limited, where he applies his expertise in developing advanced labelling reagents. His work has contributed to the enhancement of fluorescence detection methods, which are crucial in various scientific and medical research fields.
Collaborations
Cooper has collaborated with notable colleagues, including Peter Gordon Laughton and Nicholas John Gardner. These collaborations have likely enriched his research and contributed to the development of innovative solutions in the field of fluorescence labelling.
Conclusion
Michael Edward Cooper's contributions to the field of fluorescence labelling reagents exemplify the impact of innovative thinking in scientific research. His work continues to influence the way biological materials are detected and analyzed, showcasing the importance of advancements in this area.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile